https://mertk-signal.com/index.....php/isocitrate-dehy
In terms of the baseline, Brazil was the chosen country. Based on the model's findings, the B1 regimen was identified as the optimum for reducing bed-days in people under 70 years old, whereas B2 was optimal for those 70 years or older. Compared to NB, the number of bed-days was reduced by 75%, hospital admissions by 68%, and intensive care unit admissions by a significant 90%. Total costs were cut by 60% and medical resource use experienced an 81% reduction. V